What is the fatality rate in untreated insulin overdose?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: September 14, 2025View editorial policy

Personalize

Help us tailor your experience

Which best describes you? Your choice helps us use language that's most understandable for you.

Fatality Rate in Untreated Insulin Overdose

Severe hypoglycemia from untreated insulin overdose has a high mortality rate, with death occurring within minutes to hours if left untreated, as permanent brain damage develops rapidly due to the brain's inability to meet its energy needs. 1

Mortality Risk Factors

The fatality risk from untreated insulin overdose is influenced by several factors:

  • Patient characteristics that increase mortality risk:

    • Advanced age (≥75 years)
    • Multiple comorbidities
    • Cardiovascular disease
    • Renal insufficiency
    • Septic shock
    • Mechanical ventilation
    • Higher illness severity scores 1
  • Overdose characteristics:

    • Type of insulin (long-acting analogs like glargine and detemir cause extremely prolonged effects, often lasting 48-96 hours) 2
    • Intentional vs. accidental (65% of overdose cases are suicides, 23% accidental, and 12% homicidal) 3
    • Time to treatment (delayed treatment significantly increases mortality risk)

Pathophysiology of Death

Untreated insulin overdose leads to:

  1. Severe hypoglycemia causing:

    • Neuronal depletion/necrosis (29.1% of autopsy findings) 3
    • Cerebral edema in severe cases 1
    • Seizures and unconsciousness
  2. Secondary complications:

    • Pulmonary edema (55.7% of autopsy findings) 3
    • Pulmonary congestion (41.8% of autopsy findings) 3
    • Electrolyte disturbances (hypokalemia, hypophosphatemia, hypomagnesemia) 4

Evidence on Mortality Rates

While specific percentages for untreated insulin overdose fatality are not clearly established in the available evidence, several indicators suggest high mortality:

  • Hypoglycemia is independently associated with increased mortality risk (odds ratio 3.233,95% CI [2.251,4.644]; p < .0001) in critically ill patients, even with mild-moderate hypoglycemia (blood glucose 54-63 mg/dL) 1

  • In ICU settings, hypoglycemia increased mortality rate approximately twofold, though one study found this not statistically significant (RR: 1.2, CI: 0.927-1.58, P = 0.221) 5

  • In cases of intentional insulin overdose, prolonged dextrose infusion (up to 40 hours) is often required for survival 4

Treatment Implications

The high fatality risk of untreated insulin overdose underscores the importance of:

  1. Immediate intervention with:

    • Continuous intravenous 10% or 20% glucose infusion
    • Frequent capillary blood glucose monitoring
    • In extreme cases, surgical excision of the insulin injection site (effective even days after overdose) 2
  2. Monitoring for complications:

    • Electrolyte abnormalities
    • Neurological status
    • Cardiac function

Clinical Pitfalls

  • Diagnostic challenges: Postmortem toxicology screening of insulin is difficult due to the chemical characteristics of insulin and challenges distinguishing between endogenous and exogenous insulin 6

  • Treatment duration: The effects of long-acting insulin analogs can persist for 48-96 hours, requiring extended monitoring and treatment 2

  • Rebound hyperglycemia: After treating the overdose, careful reintroduction of diabetes treatment is essential, especially in patients with type 1 diabetes 2

In conclusion, untreated insulin overdose carries an extremely high mortality risk with death occurring rapidly due to neurological damage from severe hypoglycemia, making immediate recognition and aggressive treatment essential for survival.

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.